http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_333e5e07047ff44a7a5138f7cb87816b
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Dewerchin |
| name | Mieke Dewerchin |
| given-name | Mieke |
| organization-name | Laboratory of Angiogenesis and Vascular Metabolism Department of Oncology KU Leuven Leuven Belgium; Laboratory of Angiogenesis and Vascular Metabolism Center for Cancer Biology VIB Leuven Belgium From the Vesalius Research Center (X.L., M.T., I.V.H., E.N., T.D.J., E.C., H.W., M.D., P.C., L.M.), VIB, 3000 Leuven, Belgium; Vesalius Research Center (X.L., M.T., IV.H., E.N., T.D.J., E.C., H.W., M.D., P.C., L.M.), K.U. Leuven, 3000 Leuven, Belgium; Ludwig Institute for Cancer Research (X.L., M.V., U.E.), Karolinska Institute, Stockholm, Sweden; Molecular/Cancer Biology Laboratory (B.E., K.P., M.J., K.A.), Biomedicum Helsinki, University of Helsinki, Finland; Division of Cardiology (R.E.S., M.L.S.... *The Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium; ‡Chiron Corporation, Emeryville, California; §The Haemobiology Research Department, Sanofi Recherche, Toulouse, France; and ‖The Vascular Biology Laboratory, The Thrombosis Research Institute, London, UK Vesalius Research Center (VRC), Katholieke Universiteit Leuven, 3000 Leuven, Belgium; Vesalius Research Center (VRC), VIB, B-3000 Leuven, Belgium From the Center for Molecular and Vascular Biology (T.K., H.R.L., I.V., J.V., M.F.H.), University of Leuven and Center for Transgene Technology and Gene Therapy (M.D.), Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium. Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Faculty of Medicine, Catholic University of Leuven Department of Oncology, Laboratory of Angiogenesis and Vascular Metabolism, Katholieke Universiteit Leuven (KU Leuven), Leuven, Belgium;; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, Vlaams Instituut voor Biotechnologie (VIB), Leuven, Belgium; Laboratory of Angiogenesis & Neurovascular link Vesalius Research Center VIB Leuven Belgium; Laboratory of Angiogenesis & Neurovascular link Department of Oncology KU Leuven Leuven Belgium Vesalius Research Center, Vlaams Iustituut voor Biotechnologie (VIB), Leuven, Belgium;; Vesalius Research Center, Katholieke Universiteit Leuven, Leuven, Belgium; From the Center for Transgene Technology and Gene Therapy (M.D., G.W., L. Moons, D.C., P.C.), VIB, KULeuven Campus Gasthuisberg O&N, Leuven, Belgium; Cardiovascular/Thrombosis Research Department (J.-P.H., M.P., P.S., L. Millet, J.-M.H.), Sanofi-Synthélabo, Toulouse Cedex, France; Hamilton Civic Hospitals Research Centre (J.I.W.), Hamilton, Ontario, Canada. Vesalius Research Center (VRC), Vlaams Instituut voor Biotechnologie (VIB), Leuven, Belgium;; VRC, K.U.Leuven, Leuven, Belgium; Laboratory of Angiogenesis and Neurovascular link; Department of Oncology; KU Leuven; Leuven, Belgium; Laboratory of Angiogenesis and Neurovascular link; Vesalius Research Center; VIB, Leuven, Belgium Laboratory for Angiogenesis and Neurovascular Link,; Vesalius Research Center, VIB, K.U. Leuven, B-3000 Leuven, Belgium; Laboratory of Angiogenesis and Neurovascular Link Vesalius Research Center, VIB Leuven Belgium; Laboratory of Angiogenesis and Neurovascular Link Department of Oncology KU Leuven Leuven Belgium Center for Transgene Technology and Gene Therapy, Katholieke Universiteit Leuven, Leuven, Belgium; and Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven, VIB Center for Cancer Biology, VIB , Leuven 3000 , Belgium Laboratory of Experimental Medicine and Endocrinology, Katholieke Universiteit Leuven, Leuven, B-3000 Belgium; Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Herestraat 49, Leuven, B-3000 Belgium; Department of Cell Physiology, Institute of Cellular Signaling, University Medical Centre Nijmegen, NL-6500-HB The Netherlands; and Institute of Molecular and Cellular Biosciences, University of Tokyo, Bunkyo-Ku, Tokyo 113, Japan Vesalius Research Center, VIB-KU Leuven, Leuven, Belgium Laboratory of Angiogenesis and Vascular Metabolism Department of Oncology KU Leuven Leuven Belgium; Laboratory of Angiogenesis and Vascular Metabolism Vesalius Research Center VIB Leuven Belgium Vesalius Research Center, Flanders Interuniversity Institute of Biotechnology (VIB), Leuven, Belgium; and Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, B-3000 Leuven, Belgium.; Laboratory of Angiogenesis and Vascular Metabolism, Vesalius Research Center, VIB, Leuven B-3000, Belgium. Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, University of Leuven, Leuven, Belgium; Laboratory of Angiogenesis and Vascular Metabolism, Vesalius Research Center, Leuven, Belgium Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, 3000 Leuven, Belgium From the INSERM, U740 and Univ Paris Diderot, Sorbonne Cité, UMR S740, Paris, France (E.C., C.B.-M., V.D.-D., S.C., C.F., M.M.-L., A.J.); and Laboratory of Angiogenesis & Neurovascular Link, Vesalius Research Center, VIB–KU Leuven, Leuven, Belgium (M.D.). From the Deutsches Herzzentrum und 1. Medizinische Klinik der Technischen Universität München (I.O., C.M., M.S., B.S., I.S., D.Z., R.W., A.S.), Germany; Zentrum für präklinische Forschung, Klinikum rechts der Isar der Technischen Universität München (C.M., M.S.), Germany; Center for Transgene Technology and Gene Therapy (M.D., P.C.), Leuven, Belgium; Institut für Pathologie (M.R.), Klinikum rechts der Isar der Technischen Universität München, Germany Department of Oncology and Leuven Cancer Institute (LKI), Laboratory of Angiogenesis and Vascular Metabolism, KU Leuven, 3000 Leuven, Belgium; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, 3000 Leuven, Belgium Vesalius Research Center, VIB-K.U.Leuven, Campus Gasthuisberg, Leuven, Belgium; Laboratory of Angiogenesis and Neurovascular link, Vesalius Research Center, VIB, 3000 Leuven, Belgium; Laboratory of Angiogenesis and Neurovascular link, Vesalius Research Center, KU Leuven, 3000 Leuven, Belgium 4Laboratory of Angiogenesis and Neurovascular Link, Vesalius Research Center, VIB and KU Leuven, Leuven, Belgium. VIB Vesalius Research Center, KU Leuven From the Vesalius Research Center, Flanders Institute for Biotechnology (VIB), Leuven, Belgium (G.W., D.N., J.S., A.V.N., L.M., P.C., D.C., M.D.); Vesalius Research Center (G.W., D.N., J.S., A.V.N., L.M., P.C., D.C., M.D.) and Laboratory of Biological Psychology (Z.C.-V., R.D.), University of Leuven, Leuven, Belgium; Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK (R.S.-M., F.L.). Department of Transgene Technology and Gene Therapy, Flanders Institute of Biotechnology (VIB), Leuven, Belgium;; Center of Transgene Technology and Gene Therapy, Katholieke Universiteit (KU) Leuven, Leuven, Belgium; From the Center for Transgene Technology and Gene Therapy (P.V., P.P., G.M., M.P., H.G., M.S., D.C., M.D., S.J.), VIB, and Department of Cardiology (S.J.), Catholic University of Leuven, Leuven, Belgium; Department of Molecular Biomedical Research (E.B., P.S., P.B.), VIB, Ghent University, Ghent, Belgium; and Cardiovascular Research Center (E.B., F.I., A.G., K.D.B.), Harvard Medical School, Charlestown, Mass. From the Center for Molecular and Vascular Biology, University of Leuven, and Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Leuven, Belgium From the Laboratories of Physiology (M.V.H., P.V., F.W.) and Cardiology (G.A., K.S.) and the Center for Transgene Technology and Gene Therapy (S.H., M.D., D.C., P.C.), Flanders Interuniversity Institute for Biotechnology, Katholieke Universiteit Leuven, Belgium; GenomatixUSA (T.R.), Cincinnati, Ohio; Department of Physiology and Cell Biology (M.P.), Ohio State University College of Medicine and Health Sciences, Columbus, Ohio; and Département de Physiologie (B.A., J.L.), Université Catholique de... VIB-KU Leuven Center for Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Campus Gasthuisberg, University of Leuven, Leuven B-3000, Belgium Laboratory for Experimental Medicine and Endocrinology, Department of Developmental Biology, Thromb-X, Center for Molecular and Vascular Biology, and Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, and Division of Biochemistry, Gasthuisberg, Catholic University of Leuven, B-3000 Leuven, Belgium; Medical Research Council Reproductive Sciences Unit, Centre for Reproductive Biology, EH16 4SB Edinburgh, Scotland; and Unité Mixte de Recherche 6073,... From the Vesalius Research Center, VIB, Leuven, Belgium (I.G., K.H., I.S., C.R.d.A., F.D.S., W.V., F.C., S.L., M.M., H.G., A.N., T.L., P.C., and M.D.); Vesalius Research Center, K. U. Leuven, Leuven, Belgium (I.G., K.H., I.S., C.R.d.A., F.D.S., W.V., F.C., S.L., M.M., H.G., A.N., T.L., P.C., and M.D.); Hubrecht Institute-KNAW and University Medical Center, Utrecht, the Netherlands (R.H., J.B., B.M.H., and S.S.-M.); Experimental Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam,... Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, University of Leuven, Leuven, Belgium; and; Laboratory of Angiogenesis and Vascular Metabolism, Vesalius Research Center, University of Leuven, Leuven, Belgium |
Incoming Links
Total number of triples: 172.